Product image of Lenalidomide Sandoz (Lenalidomide) supplied by GNH India

Lenalidomide Sandoz

Active Ingredient:
Lenalidomide
Origin:
EU

Lenalidomide Sandoz (Lenalidomide)

Lenalidomide, the active ingredient in Lenalidomide Sandoz, is an immunomodulatory drug (IMiD) presented as an oral tablet for oral use. It is indicated for the treatment of multiple myeloma and myelodysplastic syndromes with del(5q) in adult patients.

GNH India supplies Lenalidomide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Manufacturer / TM Owner

Sandoz A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lenalidomide Sandoz is an immunomodulatory agent used in hematologic malignancies and related disorders.

  • Multiple Myeloma: improves progression‑free and overall survival in patients who have received prior therapy.
  • Myelodysplastic Syndromes with del(5q): reduces transfusion dependence and may improve blood counts.
  • Mantle Cell Lymphoma: contributes to disease control in relapsed or refractory cases.

How It Works

  • Lenalidomide binds to the cereblon component of the CRL4CRBN E3 ubiquitin ligase complex, altering substrate specificity. This leads to ubiquitination and proteasomal degradation of transcription factors Ikaros and Aiolos, resulting in anti‑angiogenic, immunomodulatory, and anti‑proliferative activities that suppress malignant plasma cells and abnormal hematopoiesis.

Side Effects

Lenalidomide may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Neutropenia: reduced neutrophil count, increasing infection risk.
  • Thrombocytopenia: lowered platelet levels, raising bleeding tendency.
  • Fatigue: persistent tiredness affecting daily activities.
  • Nausea: upset stomach, sometimes with vomiting.
  • Diarrhea: loose stools, may lead to dehydration.
  • Rash: skin irritation or erythema.

Serious or Rare Side Effects

  • Venous thromboembolism: deep vein thrombosis or pulmonary embolism.
  • Severe neutropenia: profound immune suppression, risk of serious infection.
  • Infections: opportunistic or severe bacterial, viral, or fungal infections.
  • Second primary malignancies: emergence of new cancers unrelated to original disease.
  • Embryo‑fetal toxicity: teratogenic effects leading to birth defects.
  • Hypersensitivity reactions: anaphylaxis or severe skin reactions.

Precautions & Warnings

Lenalidomide requires careful monitoring and specific safety measures.

  • Pregnancy: contraindicated; category X due to high risk of fetal harm.
  • Thromboembolism: assess risk factors and consider prophylactic anticoagulation.
  • Hematologic monitoring: regular CBC to detect neutropenia or thrombocytopenia.
  • Renal impairment: dose adjustment may be needed based on renal function.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Lenalidomide can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lenalidomide exposure.
  • Strong CYP3A4 inducers (e.g., rifampin): may reduce therapeutic effect.
  • Anticoagulants (e.g., warfarin): heightened risk of bleeding.
  • Antiplatelet agents (e.g., aspirin): additive bleeding risk.
  • Live vaccines: increased risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely)

  • CYP3A4 substrates (e.g., statins): monitor for altered plasma levels.
  • NSAIDs: may exacerbate gastrointestinal irritation.
  • Hormonal contraceptives: reduced efficacy, advise alternative contraception.
  • Immunosuppressants (e.g., cyclosporine): monitor for additive immunosuppression.
  • Vaccines (non‑live): assess immune response, may require timing adjustments.

Frequently Asked Questions

Lenalidomide Sandoz is prescribed for adult patients with multiple myeloma, myelodysplastic syndromes that have a deletion of chromosome 5q (del(5q)), and mantle cell lymphoma when other therapies have failed. It works by modifying the immune response and inhibiting the growth of malignant cells in these hematologic cancers.

Lenalidomide binds to cereblon, a component of the CRL4CRBN E3 ubiquitin ligase complex. This binding changes the complex’s substrate specificity, leading to the degradation of transcription factors Ikaros and Aiolos. The resulting actions include anti‑angiogenic effects, modulation of immune cells, and inhibition of cancer cell proliferation.

The specific dose of Lenalidomide Sandoz is determined by the prescribing physician based on the patient’s diagnosis, disease stage, renal function, and other clinical factors. Healthcare providers follow approved labeling and clinical guidelines to individualize therapy.

Lenalidomide is classified as pregnancy category X, meaning it is contraindicated in pregnancy because it can cause severe fetal harm, including birth defects. Women of childbearing potential must use effective contraception. The drug is also not recommended while breastfeeding, as it may be excreted in milk and affect the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lenalidomide belongs to the immunomodulatory drug class, offering a distinct mechanism compared with proteasome inhibitors or monoclonal antibodies. It is often used in combination regimens and can provide oral convenience. Clinical trials have shown improved progression‑free survival, but choice of therapy depends on prior treatments, patient tolerance, and disease characteristics.

Lenalidomide Sandoz tablets should be stored at temperatures below 25 °C (77 °F). Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Lenalidomide Sandoz is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

The most serious risks include severe neutropenia, thrombocytopenia, venous thromboembolism, embryo‑fetal toxicity, and the potential development of secondary malignancies. Patients should be monitored regularly for blood count changes and signs of clotting, and strict contraception is required for women of childbearing potential.

Lenalidomide Sandoz should not be used by pregnant women, individuals who are not using effective contraception, patients with known hypersensitivity to lenalidomide or its excipients, and those with uncontrolled thrombotic risk without appropriate prophylaxis. Renal impairment may also require dose adjustments or avoidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lenalidomide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT